Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending February 12, 2008. The report serves as a notification of transactions involving Directors, Persons Discharging Managerial Responsibility, or Connected Persons regarding their interests in the company's Ordinary shares.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is strictly a regulatory disclosure of share transactions and does not contain financial performance data.
Material Changes
The filing details the acquisition of Ordinary shares by five individuals (Mr. J S Heslop, Mr. R M Bondy, Mr. E J Gray, Mr. D Learmouth, and Mr. A P Witty) on February 11, 2008. Each individual acquired 11 shares through the personal contribution element and 11 shares through the matching element of the Company's ShareReward Plan. The purchase price was GBP 10.95 per share.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document is limited to the notification of the specific share transactions described above in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).
Investor Verification Points
- Verify the share price of GBP 10.95 per Ordinary share on February 11, 2008.
- Confirm the total number of shares acquired by each named director (22 shares per person: 11 personal, 11 matching).
- Review the terms of the ShareReward Plan entered into on October 5, 2001, to understand the matching contribution structure.